Viburnum opulus 28C, Phosphoric acidum 28C, Tilia europaea 28C, Guajacum 28C
Viburnum opulus 28C, Phosphoric acidum 28C, Tilia europaea 28C, Guajacum 28C · GUAIACUM OFFICINALE RESIN 28 [hp_C]/L; PHOSPHORIC ACID 28 [hp_C]/L; TILIA X EUROPAEA FLOWER 28 [hp_C]/L; VIBURNUM OPULUS BARK 28 [hp_C]/L · Liquid · Herbamed AG
NDC 64743-0461-01 · .5 L in 1 CANISTER · DRUG FOR FURTHER PROCESSING · View full market →
Bulk ingredient — not a finished product
This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.
Medicare Part D
This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Viburnum opulus 28C, Phosphoric acidum 28C, Tilia europaea 28C, Guajacum 28C (Liquid)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Herbamed AG | GUAIACUM OFFICINALE RESIN 28 [hp_C]/L; PHOSPHORIC ACID 28 [hp_C]/L; TILIA X EUROPAEA FLOWER 28 [hp_C]/L; VIBURNUM OPULUS BARK 28 [hp_C]/L | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Viburnum opulus 28C, Phosphoric acidum 28C, Tilia europaea 28C, Guajacum 28C — NDC 64743-0461-01," retrieved September 3, 2026, https://drugdashboards.com/drug/64743046101.
Free to cite with attribution — see how the data is put together.